Information Library

Results for: Phase II/III - Africa - South Africa

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Energizing Enrollment

    Case Study — October 4, 2011
    The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned.

  • Partnering is Key to Maximizing Rewards in Emerging Markets

    Press Release — September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

  • Malaria Prevention in Sub-Saharan Africa

    Case Study — June 24, 2011
    This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands

  • Constant Vigilance

    Case Study — March 16, 2011
    Centralized planning played a key role in improving productivity during site visits and close monitoring ensured the high standards Quintiles put in place were met.

  • Recruiting Trust

    Case Study — March 16, 2011
    Quintiles enrolls 2 cancer trials, 2 times faster than projected

  • Acute Coronary Syndrome - Tailored Solutions

    Case Study — February 1, 2011
    Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO.

  • Managing Trauma

    Case Study — September 14, 2010
    Quintiles overcame the unpredictability of patient recruitment due to the emergency setup and the client was able to file for approval based on phase II data only.

  • New FDA Guidance on Antidiabetic Therapies

    White Paper — December 11, 2009
    Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

  • Coordinating Safety Across Functions and Phases

    Case Study — November 3, 2009
    Facing significant challenges with clinical and post-marketing safety, a customer needed an ally who could provide a full range of safety and risk management solutions.

Page 1 of 1 (9 results)

Subscribe to Email Based on Your Interests

Set preferences